Ország: Ausztrália
Nyelv: angol
Forrás: Department of Health (Therapeutic Goods Administration)
ondansetron, Quantity: 4 mg
Dr Reddys Laboratories Australia Pty Ltd
Tablet, orally disintegrating
Excipient Ingredients: crospovidone; magnesium stearate; sodium lauryl sulfate; mannitol; colloidal anhydrous silica; pregelatinised maize starch; microcrystalline cellulose; aspartame; Guar Gum; Flavour
Oral
4 tablet, 6 tablets, 10 tablet
(S4) Prescription Only Medicine
Prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy.
Visual Identification: White to off-white, round, biconvex, uncoated tablets embossed '4' on one side and 'O' on the other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 3 Years; Container Temperature: Store below 30 degrees Celsius; Container Closure: Child resistant closure
Licence status A
2017-10-26